CNE100001JM9
CNE100001JM9
SICHUAN HEBANG BIOTECHNOLOGY CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 19.69B EUR | 20.49B EUR | 24.82B EUR | 19.96B EUR |
Enterprise Value | 20.39B EUR | 22.07B EUR | 27.07B EUR | 21.97B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 3.28x | -- | -- | -- |
Price to Sales | 3.2x | 4.94x | 5.12x | 3.85x |
Price to Book | 0.97x | 1.06x | 1.37x | 1.12x |
EV/Revenue | 3.31x | 5.32x | 5.59x | 4.24x |
EV/EBITDA | 16.09x | 40.78x | 107.77x | 199.95x |
Price to FCF (P/FCF) | -- | -- | 2,894.48x | -- |
EV/FCF | -- | -- | 3,157.82x | -- |
FCF Yield | -1.21% | -1.42% | 0.03% | -0.73% |